Media

Börje Haraldsson appointed CEO of Oncorena AB

Carisma Therapeutics to Host Webcast on Phase 1 Clinical Trial of Engineered Macrophage Therapy

BONESUPPORT achieves private coverage in South Africa

Vicore announces first human dosed with novel ATRAG, C106

Fusion Pharmaceuticals Presents Imaging Data From Cold Antibody Sub-Study In The Phase 1 Study Of FPI-1434

Fusion Pharmaceuticals And Niowave Announce Actinium-225 Collaboration And Supply Agreement

Nordic Nanovector Announces that the data from the LYMRIT 37-05 Phase 1 Trial of Betalutin® in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) will be presented at EHA 2022 Meeting

Precirix presents preclinical data of its FAP-targeting compound at the SNMMI annual meeting

Ariceum Therapeutics Launches with EUR 25M Series A to Advance Lead Asset, Satoreotide, for the Treatment of Low- and High-Grade Neuroendocrine Cancers

Vicore amends primary endpoint to accelerate the Phase 3 trial in COVID-19 patients